Letters Section Editor: Jody W. Zylke, MD, Senior Editor.
Author Affiliations: Maimonides Medical Center, Brooklyn, New York (email@example.com).
To the Editor: The study by Dr Athan and colleagues1 about the clinical characteristics and outcomes of CDIE evaluated the association between device removal and clinical outcomes. We would like to raise a few points about the analysis that may be pertinent.
First, cardiac resynchronization therapy is another predictor of long-term mortality after infection of cardiac implantable devices.2 It would be interesting to know if the authors investigated differences in the rate of infection and mortality in patients with dual-chamber pacemakers vs ventricular pacemakers.
Sharma A, Vallakati A. Cardiac Device Infective Endocarditis and Patient Survival. JAMA. 2012;308(8):761. doi:10.1001/jama.2012.9240